Compounds > n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium

n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Multiple-Myeloma

n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Multiple-Myeloma

Article	Year
18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection. Clinical nuclear medicine, 2016, Volume: 41, Issue:5 F-choline PET/CT was performed for suspected prostate cancer relapse in a 67-year-old man with hip pain and a rapid rise in prostate-specific antigen values (1.1 ng/mL). PET imaging showed an area of increased F-choline bone uptake in the right ischium. Coregistered CT images showed a lytic bone lesion. The infrequent CT appearance of a possible prostate carcinoma metastasis led to additional laboratory testing that showed a monoclonal γ-peak and to subsequent biopsy, which revealed a solitary plasmocytoma. Topics: Aged; Bone Neoplasms; Carcinoma; Choline; Humans; Incidental Findings; Male; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals	2016

Article

Year

18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.

Clinical nuclear medicine, 2016, Volume: 41, Issue:5

F-choline PET/CT was performed for suspected prostate cancer relapse in a 67-year-old man with hip pain and a rapid rise in prostate-specific antigen values (1.1 ng/mL). PET imaging showed an area of increased F-choline bone uptake in the right ischium. Coregistered CT images showed a lytic bone lesion. The infrequent CT appearance of a possible prostate carcinoma metastasis led to additional laboratory testing that showed a monoclonal γ-peak and to subsequent biopsy, which revealed a solitary plasmocytoma.

Topics: Aged; Bone Neoplasms; Carcinoma; Choline; Humans; Incidental Findings; Male; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals

2016